(0.31%) 5 033.88 points
(0.41%) 38 058 points
(0.58%) 15 697 points
(-0.22%) $78.83
(4.35%) $2.02
(0.04%) $2 312.00
(0.75%) $26.95
(0.79%) $962.45
(0.29%) $0.936
(0.28%) $11.06
(0.31%) $0.801
(-1.40%) $91.95
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 4.96%
@ $27.68
Išleistas: 14 vas. 2024 @ 22:25
Grąža: -0.65%
Ankstesnis signalas: vas. 14 - 18:01
Ankstesnis signalas:
Grąža: -0.29 %
Live Chart Being Loaded With Signals
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 168 209 |
Vidutinė apimtis | 568 296 |
Rinkos kapitalizacija | 1.26B |
EPS | $0 ( 2024-04-30 ) |
Kita pelno data | ( $0 ) 2024-07-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -61.11 |
ATR14 | $0.200 (0.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Manley Corey J | Sell | 83 | Common Stock |
2024-03-15 | Spears Joseph Brian | Sell | 56 | Common Stock |
2024-02-27 | Manley Corey J | Buy | 31 965 | Common Stock |
2024-02-27 | Etta Nchacha | Buy | 37 853 | Common Stock |
2024-02-27 | Lipps Randall A | Buy | 107 251 | Common Stock |
INSIDER POWER |
---|
61.26 |
Last 96 transactions |
Buy: 375 105 | Sell: 205 180 |
Tūris Koreliacija
Omnicell Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Omnicell Inc Koreliacija - Valiuta/Žaliavos
Omnicell Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $1.15B |
Bruto pelnas: | $499.93M (43.58 %) |
EPS: | $-0.450 |
FY | 2023 |
Pajamos: | $1.15B |
Bruto pelnas: | $499.93M (43.58 %) |
EPS: | $-0.450 |
FY | 2022 |
Pajamos: | $1.30B |
Bruto pelnas: | $588.99M (45.45 %) |
EPS: | $0.130 |
FY | 2021 |
Pajamos: | $1.13B |
Bruto pelnas: | $554.65M (49.00 %) |
EPS: | $1.784 |
Financial Reports:
No articles found.
Omnicell Inc
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.